A survey of congenital Chagas' disease, carried out at three health institutions in São Paulo City, Brazil.

The congenital transmission of Chagas' disease was evaluated in 57 pregnant women with Chagas' disease and their 58 offspring. The patients were selected from three Health Institutions in São Paulo City. The maternal clinical forms of Chagas' disease were: indeterminate (47.4%), cardiac (43.8%) and digestive (8.8%); 55 were born in endemic areas and two in São Paulo City. The transmission of Chagas' disease at fetal level was confirmed in three (5.17%) of the 58 cases studied and one probably case of congenital Chagas' disease. Two infected infants were born to chagasic women with HIV infection and were diagnosed by parasitological assays (microhematocrit, quantitative buffy coat-QBC or artificial xenodiagnosis). In both cases the placenta revealed T. cruzi and HIV p24 antigens detected by immunohistochemistry. In one case, a 14-week old abortus, the diagnosis of congenital T. cruzi infection was confirmed by immunohistochemistry. The other probable infection, a 30-week old stillborn, the parasites were found in the placenta and umbilical cord. The Western blot method using trypomastigote excreted/secreted antigens of T. cruzi (TESA) was positive for IgG antibodies in 54/55 newborns and for IgM in 1/55 newborns. One of the two newborns with circulating parasites had no detectable IgG or IgM antibodies. The assessment of IgG antibodies in the sera of pregnant women and their newborns was performed by ELISA using two different T. cruzi antigens: an alkaline extract of epimastigotes (EAE) and trypomastigote excreted/secreted antigens (TESA). The analysis showed a linear correlation between maternal and newborn IgG antibody titers at birth.

[1]  M. Lopes,et al.  Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Gruber,et al.  Trypanosoma cruzi defined antigens in the serological evaluation of an outbreak of acute Chagas disease in Brazil (Catolé do Rocha, Paraíba). , 1996, Memorias do Instituto Oswaldo Cruz.

[3]  J. Coura,et al.  Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease , 1996, Journal of clinical microbiology.

[4]  V. A. Neto,et al.  Avaliação do sistema quantitative buffy coat (QBC) no diagnóstico laboratorial da infecção pelo Trypanosoma cruzi: estudo em modelo experimental murino , 1996 .

[5]  C. Darras,et al.  Chagas congénito en Bolivia: estúdio comparativo de la eficacia y el costo de los métodos de diagnostico , 1995 .

[6]  J. Altcheh,et al.  Congenital Chagas' disease: diagnostic and clinical aspects. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Lorca,et al.  Diagnostic value of detecting specific IgA and IgM with recombinant Trypanosoma cruzi antigens in congenital Chagas' disease. , 1995, The American journal of tropical medicine and hygiene.

[8]  J. Altcheh,et al.  Perinatal human immunodeficiency virus infection and congenital Chagas' disease. , 1995, The Pediatric infectious disease journal.

[9]  D. Fabbro,et al.  [Congenital Chagas disease in the city of Santa Fé. Diagnosis and treatment]. , 1995, Medicina.

[10]  B. Zingales,et al.  Trypanosoma cruzi: studies on the reactivity of antibodies bound to the surface of blood forms at the early phase of infection. , 1994, Acta tropica.

[11]  A. Bittencourt Possible risk factors for vertical transmission of Chagas' disease. , 1992, Revista do Instituto de Medicina Tropical de Sao Paulo.

[12]  A. Rubinstein,et al.  Maternofetal transmission of AIDS: frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA. , 1992, The Journal of infectious diseases.

[13]  H. Farzadegan,et al.  Localization of human immunodeficiency virus core antigen in term human placentas. , 1992, Pediatrics.

[14]  W. Borkowsky,et al.  Pathology and human immunodeficiency virus expression in placentas of seropositive women. , 1991, The Journal of infectious diseases.

[15]  C. Darras,et al.  [Prospective study of Chagas disease in newborn children with placental infection caused by Trypanosoma cruzi (Santa Cruz-Bolivia)]. , 1991, Revista da Sociedade Brasileira de Medicina Tropical.

[16]  A. Frasch,et al.  Fetal IgG specificities against Trypanosoma cruzi antigens in infected newborns. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Rabson,et al.  HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission. , 1989, The Journal of infectious diseases.

[18]  B. Basso,et al.  [Neonatal Chagas disease: laboratory diagnosis during the first year of life]. , 1989, Medicina.

[19]  G. Landman,et al.  Identification of Trypanosoma cruzi in human tissues using an immunoperoxidase method: study of acute Chagas disease, congenital form. , 1986, Allergologia et immunopathologia.

[20]  A. J. A. Barbosa,et al.  Doença de Chagas congênita: avaliação imunocitoquímica do parasitismo em tecidos de feto macerado , 1986 .

[21]  J. Maguire,et al.  Incidence of congenital Chagas' disease in Bahia, Brazil. , 1985, Journal of tropical pediatrics.

[22]  A. L. Bittencourt Doença de Chagas Congênita na Bahia , 1984 .

[23]  M. Sadigursky,et al.  [Congenital Chagas' disease. Study of 29 cases]. , 1975, Revista do Instituto de Medicina Tropical de Sao Paulo.

[24]  A. AUCHTER DE MANERO,et al.  [Congenital Chagas' disease]. , 1958, Revista medica de Cordoba.